Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction.

VEGF cardiac regeneration endothelial cells heart failure lymphangiogenesis myocardial infarction neovascularisation

Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
08 2023
Historique:
revised: 14 04 2023
received: 01 03 2023
accepted: 27 04 2023
medline: 29 8 2023
pubmed: 5 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Myocardial infarction, caused by a thrombus or coronary vascular occlusion, leads to irreversible ischaemic injury. Advances in early reperfusion strategies have significantly reduced short-term mortality after myocardial infarction. However, survivors have an increased risk of developing heart failure, which confers a high risk of death at 1 year. The capacity of the injured neonatal mammalian heart to regenerate has stimulated extensive research into whether recapitulation of developmental regeneration programmes may be beneficial in adult cardiovascular disease. Restoration of functional blood and lymphatic vascular networks in the infarct and border regions via neovascularisation and lymphangiogenesis, respectively, is a key requirement to facilitate myocardial regeneration. An improved understanding of the endogenous mechanisms regulating coronary vascular and lymphatic expansion and function in development and in adult patients after myocardial infarction may inform future therapeutic strategies and improve translation from pre-clinical studies. In this review, we explore the underpinning research and key findings in the field of cardiovascular regeneration, with a focus on neovascularisation and lymphangiogenesis, and discuss the outcomes of therapeutic strategies employed to date. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Identifiants

pubmed: 37272582
doi: 10.1002/path.6093
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

666-678

Subventions

Organisme : British Heart Foundation
ID : FS/16/4/31831
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/4yPhD/F/20/34126
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/13/3/30183
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RM/17/3/33381
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Références

Front Physiol. 2018 May 23;9:557
pubmed: 29875677
Metabolites. 2022 Nov 08;12(11):
pubmed: 36355163
Aging (Albany NY). 2012 Dec;4(12):966-77
pubmed: 23425860
Theranostics. 2021 Jan 1;11(1):268-291
pubmed: 33391474
Circulation. 2002 Apr 30;105(17):2012-8
pubmed: 11980678
Int J Mol Sci. 2019 Sep 07;20(18):
pubmed: 31500313
Exp Cell Res. 2006 Mar 10;312(5):575-83
pubmed: 16343484
Elife. 2019 Nov 08;8:
pubmed: 31702554
Theranostics. 2019 Aug 9;9(19):5694-5705
pubmed: 31534512
Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H741-51
pubmed: 25015963
Science. 2017 Jun 9;356(6342):1035-1039
pubmed: 28596337
Science. 2002 Dec 13;298(5601):2188-90
pubmed: 12481136
JACC Heart Fail. 2015 Mar;3(3):234-42
pubmed: 25742760
Sci Rep. 2018 Nov 30;8(1):17509
pubmed: 30504800
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Circulation. 2000 Jun 27;101(25):2981-8
pubmed: 10869273
Dev Cell. 2019 Nov 18;51(4):503-515.e4
pubmed: 31743664
Cardiovasc Res. 2018 Sep 1;114(11):1411-1421
pubmed: 30016405
Cell. 2020 Feb 20;180(4):764-779.e20
pubmed: 32059779
PLoS One. 2012;7(9):e44692
pubmed: 23028582
Ann Thorac Surg. 2014 May;97(5):1643-50
pubmed: 24792251
Hypertens Res. 2003 Feb;26 Suppl:S121-7
pubmed: 12630822
Nat Commun. 2021 Jan 4;12(1):84
pubmed: 33398012
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1617-24
pubmed: 21474827
Eur Heart J. 2017 Sep 01;38(33):2547-2555
pubmed: 28903476
Cell. 2015 Jun 18;161(7):1566-75
pubmed: 26073943
J Am Heart Assoc. 2018 Nov 6;7(21):e010355
pubmed: 30554564
Circ Res. 1991 Jun;68(6):1713-21
pubmed: 2036720
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202457
Nature. 2020 May;581(7808):303-309
pubmed: 32214235
Cell Rep. 2022 Dec 27;41(13):111891
pubmed: 36577384
J Clin Invest. 2017 Aug 1;127(8):2968-2981
pubmed: 28650345
BMJ. 2019 Feb 13;364:l223
pubmed: 30760447
Sci Rep. 2018 Nov 12;8(1):16709
pubmed: 30420641
Commun Biol. 2021 Jan 29;4(1):146
pubmed: 33514846
Nat Rev Cardiol. 2020 Dec;17(12):790-806
pubmed: 32587347
J Pharmacol Sci. 2012;119(3):198-203
pubmed: 22786561
Histochem Cell Biol. 2020 Nov;154(5):533-548
pubmed: 32926230
EClinicalMedicine. 2022 Jun 27;50:101530
pubmed: 35799845
Nat Commun. 2021 Jan 29;12(1):681
pubmed: 33514719
Am Heart J. 2011 Mar;161(3):581-9
pubmed: 21392615
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12245-E12254
pubmed: 30530645
Circulation. 2003 Jun 3;107(21):2677-83
pubmed: 12742981
Science. 2011 Feb 25;331(6020):1078-80
pubmed: 21350179
Circulation. 2020 May 26;141(21):1704-1719
pubmed: 32098504
Nature. 2015 Jun 11;522(7555):226-230
pubmed: 25938716
JCI Insight. 2017 Jun 15;2(12):
pubmed: 28614788
J Clin Invest. 2011 May;121(5):1894-904
pubmed: 21505261
Heart. 2001 Jun;85(6):639-42
pubmed: 11359743
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Science. 2009 Apr 3;324(5923):98-102
pubmed: 19342590
Nat Commun. 2018 Oct 30;9(1):4435
pubmed: 30375404
Cell Discov. 2019 Jun 4;5:30
pubmed: 31231540
Eur Heart J. 2019 Aug 7;40(30):2507-2520
pubmed: 31162546
Circ Res. 2002 Nov 29;91(11):988-98
pubmed: 12456484
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):615-9
pubmed: 11149956
Sci Rep. 2017 Aug 2;7(1):7156
pubmed: 28769049
FASEB J. 2002 Jul;16(9):1117-9
pubmed: 12039855
Microcirculation. 2014 Aug;21(6):532-40
pubmed: 24654984
J Gene Med. 2022 Aug;24(8):e3437
pubmed: 35750637
Circulation. 2018 Dec 11;138(24):2798-2808
pubmed: 30030417
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1118-1127.e1
pubmed: 29452461
J Exp Zool. 1974 Feb;187(2):249-53
pubmed: 4813417
Front Cell Dev Biol. 2022 Jun 06;10:883861
pubmed: 35733851
Circulation. 2020 Nov 10;142(19):1831-1847
pubmed: 32972203
Cardiovasc Res. 2023 Jan 18;118(17):3272-3287
pubmed: 35150240
Nat Rev Genet. 2020 Sep;21(9):511-525
pubmed: 32504079
Front Oncol. 2020 Jul 16;10:1140
pubmed: 32766149
Science. 2022 May 13;376(6594):eabl4896
pubmed: 35549404
Dev Cell. 2016 Feb 22;36(4):362-74
pubmed: 26906733
J Clin Invest. 2021 Oct 15;131(20):
pubmed: 34403369
J Cardiovasc Pharmacol. 2010 Oct;56(4):413-9
pubmed: 20930593
Circulation. 2022 Oct 4;146(14):1105-1108
pubmed: 36191067
J Biol Chem. 2009 Jun 5;284(23):16037-48
pubmed: 19366703
Nat Cardiovasc Res. 2022 Mar;1(3):263-280
pubmed: 35959412
Nat Commun. 2016 Jul 22;7:12260
pubmed: 27447449
Bull Exp Biol Med. 2002 Aug;134(2):203-5
pubmed: 12459851
Circulation. 2018 Jul 10;138(2):166-180
pubmed: 29386203
Br Heart J. 1951 Jan;13(1):37-42
pubmed: 14791881
Cardiovasc Res. 2010 Jul 15;87(2):331-9
pubmed: 20472566
Circulation. 2018 Dec 11;138(24):2809-2816
pubmed: 30030418
Curr Vasc Pharmacol. 2006 Apr;4(2):95-100
pubmed: 16611152
Small Methods. 2022 Mar;6(3):e2100752
pubmed: 35023642
Biochim Biophys Acta. 2013 Dec;1832(12):2414-24
pubmed: 24036209
Circulation. 2020 Aug 4;142(5):466-482
pubmed: 32403949
Nature. 2020 Dec;588(7838):466-472
pubmed: 32971526
Nat Commun. 2017 Jul 24;8:16034
pubmed: 28737171
Angiogenesis. 2021 May;24(2):213-236
pubmed: 33844116
Histopathology. 2007 Sep;51(3):345-53
pubmed: 17727476
Nature. 2022 Aug;608(7924):766-777
pubmed: 35948637
Front Cardiovasc Med. 2019 Jul 17;6:91
pubmed: 31380393
Circ Res. 2016 Jan 22;118(2):216-21
pubmed: 26659640
Biochim Biophys Acta. 2014 Jan;1840(1):454-63
pubmed: 24112971
Cardiovasc Res. 2023 Mar 17;119(1):136-154
pubmed: 36082978
Development. 2011 May;138(9):1663-74
pubmed: 21429987
J Clin Invest. 2014 Jul;124(7):2921-34
pubmed: 24937432
Cardiovasc Res. 2008 May 1;78(2):315-23
pubmed: 18065770
J Am Heart Assoc. 2018 Oct 2;7(19):e009565
pubmed: 30371303
Elife. 2019 Mar 26;8:
pubmed: 30912746
Mol Endocrinol. 2007 Apr;21(4):783-96
pubmed: 17053041
Nat Rev Cardiol. 2018 Oct;15(10):579-580
pubmed: 30190531
J Exp Med. 2021 Sep 6;218(9):
pubmed: 34325467
Cardiovasc Res. 2001 Feb 16;49(3):543-53
pubmed: 11166267
Nat Cell Biol. 2020 Jan;22(1):108-119
pubmed: 31915373
Physiol Genomics. 2019 Jun 1;51(6):186-196
pubmed: 30978160
Nat Rev Drug Discov. 2017 Oct;16(10):699-717
pubmed: 28729726
Circ Res. 2012 Jan 6;110(1):e19-e21
pubmed: 25214670
Nature. 2011 Jun 08;474(7353):640-4
pubmed: 21654746
Physiol Rev. 2013 Oct;93(4):1743-802
pubmed: 24137021
Cardiovasc Res. 2021 Apr 23;117(5):1257-1273
pubmed: 33063086
Front Bioeng Biotechnol. 2018 Feb 12;6:7
pubmed: 29484295
Circ Res. 2019 Jan 4;124(1):101-113
pubmed: 30582443
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1722-1737
pubmed: 32404007
Antioxid Redox Signal. 2013 Mar 20;18(9):1100-13
pubmed: 22870932
Cardiovasc Res. 2011 Sep 1;91(4):565-76
pubmed: 21742674
Mol Ther Methods Clin Dev. 2018 Apr 10;9:330-346
pubmed: 30038937
Int J Cardiol. 2013 Sep 10;167(6):2638-45
pubmed: 22818386
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Circulation. 2016 Apr 12;133(15):1484-97; discussion 1497
pubmed: 26933083
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11237-11242
pubmed: 27647901
J Clin Invest. 2018 Aug 1;128(8):3402-3412
pubmed: 29985167
Am Heart J. 2016 Jan;171(1):56-63
pubmed: 26699601
Nature. 2014 Oct 30;514(7524):585-90
pubmed: 25317562
Dev Cell. 2011 Mar 15;20(3):397-404
pubmed: 21397850
Nature. 1974 Mar 8;248(5444):145-7
pubmed: 4818918
Nat Biotechnol. 2013 Oct;31(10):898-907
pubmed: 24013197
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1408-1427
pubmed: 33626908
Cell. 2019 Feb 21;176(5):1128-1142.e18
pubmed: 30686582
Elife. 2021 Jun 21;10:
pubmed: 34152268
Nature. 2015 Jun 4;522(7554):62-7
pubmed: 25992544
Eur Heart J. 2017 Sep 1;38(33):2532-2546
pubmed: 28575280
Cell. 2006 Nov 3;127(3):607-19
pubmed: 17081981

Auteurs

Bronwyn Berkeley (B)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Michelle Nga Huen Tang (MNH)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Mairi Brittan (M)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH